Skip to main content
. 2016 Feb 12;11(2):e0148806. doi: 10.1371/journal.pone.0148806

Table 1. Baseline characteristics of the study population.

(N) PPI (207) H2A (119) None (366) p
Vintage (PD before 2005)(%) 64 (31.1) 87 (73.5) 255 (69.9) 0.0005
Age (years) 58.8 (16.0) 64.2 (13.7)* 57.4 (15.7) 0.0005
Gender (% males) 63.6 55.9 59.6 0.38
Diabetes (%) 85 (41.1) 44 (31.3) 117 (32.0) 0.40
Charlson’s score 4.4 (2.2) 4.4 (2.2) 3.6 (1.9)* 0.0005
Previous atherothrombotic event (%) 84 (40.6) 59 (50.0) 113 (30.9) 0.0005
Previous congestive heart failure (%) 54 (26.1) 36 (30.5) 49 (13.4) 0.0005
Modality of PD (% APD) 67 (32.4) 57 (48.3)* 135 (36.9) 0.016
Previous/Ongoing immunosuppression (%) 38 (18.4)* 8 (6.8) 16 (4.4) 0.0005
Malnutrition (%) 25 (12.1) 17 (14.4)* 25 (6.8) 0.009
GFR (mL/m) 6.7 (4.0)* 5.5 (3.7) 5.7 (3.6) 0.007
Body mass index (Kg/m2) 25.9 (4.7) 26.1 (4.7) 25.8 (4.4) 0.81
Plasma albumin (g/L) 35.5 (6.1) 36.3 (5.3) 38.1 (5.4)* 0.0005
Hemoglobin (g/dL) 10.7 (1.6) 10.6 (1.6) 10.3 (1.6) 0.055
C-reactive protein (mg/dL) 0.64(0.10, 52.4) 0.89 (0.10, 19.8) 0.53 (0.10, 16.7)** 0.016
D/P 240’ creatinine 0.67 (0.13) 0.66 (0.13) 0.65 (0.14) 0.39

PPI: Proton pump inhibitors; H2A: H2 receptor antagonists; APD: Automated PD; GFR: Glomerular filtration rate

Figures denote mean values (SD) for numerical variables, median (range) for C-reactive protein and n (%) for categorical variables. Comparisons by ANOVA (Scheffé), χ2 distribution and Mann Whitney’s test.

* Significant difference vs any other group.

** Significant difference vs H2A